How is a vitamin K (phytonadione) injection prepared?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Preparation of Vitamin K (Phytonadione) Injection

Phytonadione (vitamin K1) injection is available as a sterile, aqueous colloidal solution that requires no further preparation before administration via intravenous, intramuscular, or subcutaneous routes. 1

Formulation Details

Phytonadione injectable emulsion is a yellow, sterile, aqueous colloidal solution with the following characteristics:

  • pH range: 3.5 to 7.0
  • Each 0.5 mL contains:
    • 1 mg phytonadione (Vitamin K1)
    • 10 mg polysorbate 80
    • 10.4 mg propylene glycol
    • 0.17 mg sodium acetate anhydrous
    • 0.0002 mL glacial acetic acid
    • Nitrogen-flushed to displace air in the container 1

Administration Routes and Considerations

Intravenous Administration

  • Should be administered slowly, typically over 15-30 minutes in 25-50 mL normal saline
  • Maximum single dose should not exceed 10 mg
  • Provides more rapid correction of INR (4-6 hours) compared to oral administration
  • Risk of anaphylactic reaction is approximately 3 per 100,000 doses 2

Intramuscular Administration

  • Ready to use without further preparation
  • Commonly used in neonates for prophylaxis of vitamin K deficiency bleeding
  • Single dose administration is effective for preventing classical and early vitamin K deficiency bleeding 3

Subcutaneous Administration

  • Not recommended due to unpredictable absorption 2
  • Associated with higher risk of cutaneous reactions including localized eczematous or morphea-form reactions 4

Dosing Considerations

For Anticoagulant Reversal

  • Initial dose should be administered IV (not exceeding 10 mg)
  • For patients with elevated INR and bleeding, concurrent administration with prothrombin complex concentrate is recommended
  • Dosing based on severity:
    • For INR 2-4: 25 U/kg PCC with 5-10 mg vitamin K
    • For INR 4-6: 35 U/kg PCC with 5-10 mg vitamin K
    • For INR >6: 50 U/kg PCC with 5-10 mg vitamin K 2

For Pediatric Patients

  • Preterm and term infants up to 12 months on parenteral nutrition: 10 μg/kg/day
  • Older children on parenteral nutrition: 200 μg/day 2

Storage and Handling

  • The injectable emulsion should be stored at controlled room temperature
  • Protect from light
  • The air above the liquid in individual containers is displaced with nitrogen during manufacturing 1

Important Precautions

  • Anaphylactic reactions can occur with IV administration (3 per 100,000 doses)
  • Doses >10 mg vitamin K can prevent re-warfarinization for days and may create a prothrombotic state
  • When reversing anticoagulation, INR should be monitored regularly over the next week, as some patients may require additional vitamin K 2
  • Cutaneous reactions may occur at injection sites, particularly with subcutaneous administration, and can persist for months 4

Phytonadione injection is a ready-to-use formulation that requires no further preparation before administration, making it convenient for emergency use in anticoagulant reversal and other clinical scenarios requiring rapid vitamin K supplementation.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cutaneous reactions associated with vitamin K1.

Journal of cutaneous medicine and surgery, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.